Erythema multiforme (EM), in its modern definition, is an acute, self-limited syndrome with
distinctive skin lesions with or without mucosal lesions. Use of the terminology “EM minor” …

Toxic epidermal necrolysis is perhaps the most formidable disease encountered by
dermatologists. Uncommon but not rare, toxic epidermal necrolysis occurs in 60 to 70 …

Fifteen consecutive patients with toxic epidermal necrolysis or the Stevens-Johnson
syndrome managed without corticosteroids after transfer to the burn center (group 2) are …

Background Allopurinol is the primary therapy for the management of chronic gout.
Utilization of allopurinol has increased in tandem with the growing prevalence of gout …

Purpose: To evaluate the epidemiology, possible etiologic factors, complications
encountered, and treatment administered to a group of patients with ocular involvement in …

Purpose: To study the acute ocular/cutaneous manifestations, causes, and management of
the erythema multiforme (EM)/Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis …

In 1982, the fixed combination of pyrimethamine and sulfadoxine (Fansidar) became
available in the United States, and was recommended for use in travelers at risk of acquiring …

In this article we describe the immunocytochemical and electron microscopic findings in five
patients with toxic epidermal necrolysis. They indicate the occurrence of necrotic …

Although they were once believed to be distinct diseases, many observers currently
consider erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis …

Erythema multiforme (EM) is an acute, self-limited cutaneous or mucocutaneous disorder,
characterized by the development of symmetrically distributed, fixed, red lesions. Some …